Michele Bronson

机构：NKT Therapeutics (United States)

发表论文 11 篇 · 总被引 2966 次 · h-index 5

代表论文

• Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity (2015 · New England Journal of Medicine · 被引 1047)
• Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors (2019 · New England Journal of Medicine · 被引 959)
• Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors (2016 · New England Journal of Medicine · 被引 793)
• Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program (2013 · Cephalalgia · 被引 94)
• Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP (2014 · Cephalalgia · 被引 60)
• SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY VOLUNTEERS OF VENT-03, A NOVEL CGAS INHIBITOR FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (2025 · The Journal of Rheumatology · 被引 5)